Oct 29, 2025 8:00 am EDT LIXTE Biotechnology Holdings to Present at the Spartan Capital Investor Conference 2025, November 3
Oct 16, 2025 8:00 am EDT LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans
